Device Respiratory

Single-Use Flexible Video Bronchoscope

Payments companies reported to CMS as associated with Single-Use Flexible Video Bronchoscope. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$83Kassociated payments (2023-2025)

207clinicians with associated payments

4companies reporting

By year

2024 $22K

2025 $61K

Payments reported as associated with Single-Use Flexible Video Bronchoscope, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pulmonary Disease $63K

Pediatric Pulmonology $16K

Critical Care Medicine (Internal Medicine) $1,758

Internal Medicine $820

Hospitalist $237

Family $204

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Single-Use Flexible Video Bronchoscope

These are the largest totals companies reported as associated with Single-Use Flexible Video Bronchoscope. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Erik Hysinger	Cincinnati, OH	Pediatric Pulmonology	$15,435.65
Sonali Sethi	New York, NY	Pulmonary Disease	$11,588.82
George Cheng	San Diego, CA	Pulmonary Disease	$8,236.30
Niral Patel	San Diego, CA	Pulmonary Disease	$6,919.99
Douglas Hogarth	Chicago, IL	Pulmonary Disease	$5,399.44
Hans Lee	Baltimore, MD	Pulmonary Disease	$5,003.39
Adnan Majid	Boston, MA	Pulmonary Disease	$4,080.00
Alexander Chen	Saint Louis, MO	Pulmonary Disease	$4,076.86
Jason Akulian	Baltimore, MD	Pulmonary Disease	$3,520.00
Septimiu Murgu	Chicago, IL	Pulmonary Disease	$2,567.03

Prescribed Single-Use Flexible Video Bronchoscope?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.